News & Updates

Patient outcomes are not significantly different between the use of biologics fact sheet and the ibdandme.org (IBD&me), a freely available, unbranded, interactive decision aid, a study has shown. High satisfaction is noted with both resources.

The administration of restrictive, compared with standard, intravenous (IV) fluid therapy to patients with septic shock in the intensive care unit (ICU) did not result in a reduction in mortality risk, according to results of the CLASSIC* trial.

Use of low- and very low-dose intravitreal bevacizumab (IVB) as initial treatment for type 1 retinopathy of prematurity (ROP) leads to satisfactory retinal structural outcomes, reports a study, noting that many eyes have received additional treatment.

Treatment with amantadine appears to lower mortality among COVID-19 patients with severe respiratory failure in the intensive care unit (ICU), a retrospective study has found.

In the treatment of patients with rheumatoid arthritis (RA) and atherosclerotic cardiovascular disease (ASCVD), the use of tofacitinib confers an increased risk of major adverse cardiovascular events (MACE) than tumour necrosis factor inhibitors (TNFi), according to a post hoc analysis of ORAL Surveillance.